| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000032475 |
| Receipt No. | R000027092 |
| Scientific Title | Comparison of intrathecal morphine with continuous patient-controlled epidural anesthesia versus intrathecal morphine alone for post-cesarean section analgesia: a randomized controlled trial |
| Date of disclosure of the study information | 2018/05/06 |
| Last modified on | 2020/02/28 (Ver. 8) |
| Basic information | ||
| Public title | Comparison of intrathecal morphine with continuous patient-controlled epidural anesthesia versus intrathecal morphine alone for post-cesarean section analgesia: a randomized controlled trial | |
| Acronym | Comparison of intrathecal morphine with continuous patient-controlled epidural anesthesia versus intrathecal morphine alone for post-cesarean section analgesia: a randomized controlled trial | |
| Scientific Title | Comparison of intrathecal morphine with continuous patient-controlled epidural anesthesia versus intrathecal morphine alone for post-cesarean section analgesia: a randomized controlled trial | |
| Scientific Title:Acronym | Comparison of intrathecal morphine with continuous patient-controlled epidural anesthesia versus intrathecal morphine alone for post-cesarean section analgesia: a randomized controlled trial | |
| Region |
|
|
| Condition | ||
| Condition | pregnancy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study is to examine that the combined use of PCEA and spinal anesthesia with intrathecal morphine may have an advantage in postoperative analgesia following caesarean section compared to intrathecal morphine and single shot spinal anesthesia alone. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The primary outcome of this study is postoperative pain as measured by NRS at 12 hours after intrathecal administration of morphine at rest and during mobilization |
| Key secondary outcomes | Secondary outcomes are NRS and Bromage score at 4, 8, 24, 48 hours after intrathecal administration of morphine at rest and during mobilization, the number of patients who requested rescue analgesics, the number of requests for rescue analgesics per patient, the interval time before the first request of rescue analgesics, the incidence of delayed ambulation, and the incidence of requested treatment for pruritus and postoperative nausea and vomiting (PONV) during the first 24 hours after intrathecal administration of morphine. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | spinal anesthesia and epidural anesthesia | |
| Interventions/Control_2 | spinal anesthesia | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1.The case of the American Society of Anesthesiologists (ASA) physical status classification scale I and II and that regional anesthesia is thought to be adaptated.
2.The case that a written agreement is provided about the participation in this study. |
|||
| Key exclusion criteria | We excluded patients with contraindications for spinal or epidural anesthesia due to hemodynamic, infectious, hemostatic, neurological statuses, and medication use. In addition, we excluded cases of which we were unable to obtain informed consent such as extremely emergent caesarean sections and cases of which general anesthesia was selected for reasons such as urgency or prediction of massive hemorrhage. | |||
| Target sample size | 46 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Asahikawa Medical University | ||||||
| Division name | Department of Anesthesiology and Critical Care Medicine | ||||||
| Zip code | 078-8510 | ||||||
| Address | Midorigaoka-higashi, Asahikawa-shi, Hokkaido 078-8510, | ||||||
| TEL | 0166-68-2583 | ||||||
| iwasakih@asahikawa-med.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Asahikawa Medical University | ||||||
| Division name | Department of Anesthesiology and Critical Care Medicine | ||||||
| Zip code | 078-8510 | ||||||
| Address | Midorigaoka-higashi, Asahikawa-shi, Hokkaido 078-8510 | ||||||
| TEL | 0166-68-2583 | ||||||
| Homepage URL | |||||||
| izumihata323@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | Asahikawa Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | IRB of Kushiro Red Cross Hospital |
| Address | 21-14, Shinei-cho, Kushiro, Hokkaido, Japan |
| Tel | 0154-22-7171 |
| nakagoshi@kushiro.jrc.or.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 46 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027092 |